Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions.


Journal

Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850

Informations de publication

Date de publication:
05 2019
Historique:
received: 30 05 2018
revised: 10 08 2018
accepted: 10 08 2018
pubmed: 26 12 2018
medline: 14 8 2020
entrez: 25 12 2018
Statut: ppublish

Résumé

Conventional MRI can be limited in detecting subtle epileptic lesions or identifying active/epileptic lesions among widespread, multifocal lesions. We developed a high-resolution 3D MR fingerprinting (MRF) protocol to simultaneously provide quantitative T Prospective. National Institute of Standards and Technology (NIST) / International Society for Magnetic Resonance in Medicine (ISMRM) phantom, five healthy volunteers and 15 patients with medically intractable epilepsy undergoing presurgical evaluation with noninvasive or invasive electroclinical data. 3D MRF scans and routine clinical epilepsy MR protocols were acquired at 3 T. The accuracy of the T Phantom results were compared using R-squared, and patient results were compared using linear regression models. The phantom study showed high accuracy with the standard values, with an R The 3D MRF protocol showed potential to identify otherwise inconspicuous epileptogenic lesions from the patients with negative conventional MRI diagnosis, as well as to correlate with different levels of epileptogenicity when widespread lesions were present. 3. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2019;49:1333-1346.

Sections du résumé

BACKGROUND
Conventional MRI can be limited in detecting subtle epileptic lesions or identifying active/epileptic lesions among widespread, multifocal lesions.
PURPOSE
We developed a high-resolution 3D MR fingerprinting (MRF) protocol to simultaneously provide quantitative T
STUDY TYPE
Prospective.
POPULATION
National Institute of Standards and Technology (NIST) / International Society for Magnetic Resonance in Medicine (ISMRM) phantom, five healthy volunteers and 15 patients with medically intractable epilepsy undergoing presurgical evaluation with noninvasive or invasive electroclinical data.
FIELD STRENGTH/SEQUENCE
3D MRF scans and routine clinical epilepsy MR protocols were acquired at 3 T.
ASSESSMENT
The accuracy of the T
STATISTICAL TESTS
Phantom results were compared using R-squared, and patient results were compared using linear regression models.
RESULTS
The phantom study showed high accuracy with the standard values, with an R
DATA CONCLUSION
The 3D MRF protocol showed potential to identify otherwise inconspicuous epileptogenic lesions from the patients with negative conventional MRI diagnosis, as well as to correlate with different levels of epileptogenicity when widespread lesions were present.
LEVEL OF EVIDENCE
3. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2019;49:1333-1346.

Identifiants

pubmed: 30582254
doi: 10.1002/jmri.26319
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1333-1346

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS109439
Pays : United States
Organisme : NIBIB NIH HHS
ID : R21 EB026764
Pays : United States

Informations de copyright

© 2018 International Society for Magnetic Resonance in Medicine.

Auteurs

Dan Ma (D)

Radiology, Case Western Reserve University, Cleveland, Ohio, USA.

Stephen E Jones (SE)

Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Anagha Deshmane (A)

Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tuebingen, Germany.

Ken Sakaie (K)

Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Eric Y Pierre (EY)

Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.

Mykol Larvie (M)

Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Debra McGivney (D)

Radiology, Case Western Reserve University, Cleveland, Ohio, USA.

Ingmar Blümcke (I)

Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.
Institute of Neuropathology, University Hospitals Erlangen, Erlangen, Germany.

Balu Krishnan (B)

Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.

Mark Lowe (M)

Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Vikas Gulani (V)

Radiology, Case Western Reserve University, Cleveland, Ohio, USA.

Imad Najm (I)

Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.

Mark A Griswold (MA)

Radiology, Case Western Reserve University, Cleveland, Ohio, USA.

Z Irene Wang (ZI)

Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH